HealthRX vs Willow: Which GLP-1 Provider Is Better?
Short answer: Willow scores higher on our rubric, 7.5/10 against 5.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Willow beats HealthRX overall, scoring 7.5/10 vs 5.2/10. Published pricing is not a like-for-like monthly comparison: HealthRX is from $99/mo; Willow is from $299/mo. Choose HealthRX for cash-pay patients who want low flat-dose compounded glp-1 pricing, all-50-state access, fast shipping, and self-service cancellation. Choose Willow for users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide.
A side-by-side look at HealthRX and Willow to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
HealthRX
#49 of 54HealthRX is a cash-pay telehealth platform for compounded injectable semaglutide and tirzepatide. Its July 2026 landing page lists semaglutide at $133/mo on a 3-month plan or $99/mo on a 12-month plan, plus tirzepatide at $209/mo or $179/mo. Prices stay flat across doses and include clinician review, dose adjustments, and overnight shipping. MD Integrations supplies the clinician network, while the dispensing 503A pharmacy remains unnamed on the public site.
Visit HealthRXWillow
#19 of 54Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Offers daily oral tablets for BOTH molecules alongside the injectables, semaglutide tablets and tirzepatide tablets, at the same price as the corresponding injection.
Visit Willow| Feature | HealthRX | Willow |
|---|---|---|
| Why each one | Low flat-dose pricing paired with linked LegitScript verification, nationwide clinician coverage, overnight shipping, and self-service account cancellation. | The only compounded platform on our index with daily oral tablets for BOTH semaglutide and tirzepatide at injection-price parity, the widest needle-free menu in the compounded category. |
| Our Score | 5.2/10 | 7.5/10 |
| Headline Price | from $99/mo | from $299/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Cash-pay patients who want low flat-dose compounded GLP-1 pricing, all-50-state access, fast shipping, and self-service cancellation | Users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide |
| Watch out for | The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site | Compounded-only, no brand-name Wegovy or Zepbound through the platform |
| Ranking | #49 | #19 |
| Get started | Visit HealthRX | Visit Willow |
Pros & Cons Compared
HealthRX
Pros
- +$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
- +Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
- +Licensed clinicians in all 50 states through MD Integrations, with most files reviewed within about 24 hours
- +LegitScript certificate 50087439 links to the issuer's verification checker
- +Single-click account cancellation and refunds for unshipped doses
- +Published HIPAA notice, telehealth consent, safety information, and emergency instructions
Cons
- −The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
- −Legal entity, headquarters, executive team, and medical director remain undisclosed
- −The tirzepatide product page advertises $149/mo while the current affiliate landing and FAQ say $179/mo, so confirm the checkout rate
- −The 4.8/5 from 12,000+ members block uses illustrative composites rather than an independent review platform
- −Cash-pay only, with no insurance billing or prior-authorization support
- −Compounded medications sit outside FDA premarket approval as finished products
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Daily oral tablets for BOTH semaglutide and tirzepatide, one of the only platforms with a needle-free route on both molecules
- +$299/mo all-in for compounded semaglutide (injectable or tablet) with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only, no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide runs $399/mo against $299 for semaglutide, a $100/mo premium for the dual-pathway molecule
- −Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024, less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out HealthRX with a score of 7.5/10 vs 5.2/10. Published pricing is not a like-for-like monthly comparison: HealthRX is from $99/mo; Willow is from $299/mo.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving HealthRX and Willow.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare HealthRX and Wellorithm$147 first month, rises after
- Compare HealthRX and Telos RXpublished $99/mo; total not verified
- Compare HealthRX and SnagRxpublished $99/mo; total not verified
- Compare Willow and Maximuspublished $79.99/mo; total not verified
- Compare Willow and Embodyfrom $69/mo
- Compare Willow and PeterMD$209 first month, rises after
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Willow legit, with the verification evidence behind each answer.
Our pick of these two: Willow · 7.5/10